Table 3.
Clinical characteristics and Pathways to initiate anti-TB treatment among cases on treatment Southwest Ethiopia, January to December 2015
| Variable | Frequency (%) | Percent | |
|---|---|---|---|
| Place TB diagnosis made | Hospital | 448 | 61.0 |
| Health center | 188 | 25.6 | |
| Private clinic | 99 | 13.5 | |
| Type of TB | Smear positive Pulmonary | 373 | 50.3 |
| Smear negative Pulmonary | 213 | 29.0 | |
| Extra pulmonary | 149 | 20.3 | |
| Mode of diagnosis | Bacteriological | 373 | 50.7 |
| Clinical | 362 | 49.3 | |
| Weight at treatment initiation | Mean(SD)Kg | 48.8 | |
| HIV status | Positive | 68 | 9.3 |
| Negative | 667 | 90.7 | |
| Receiving ARTa (n = 68) | 27 | 39.7 | |
| Receiving CPTb (n = 68) | 32 | 47.1 | |
| Number of HCF visited c | Median (IQR) | 2(1–3) | |
| Number of visits made d | Median (IQR) | 3(2–4) | |
| Provider delay (days) | Median (IQR) | 22(8–48) | |
| Median(95%CI) | 22(19,25) | ||
| Total delay (days) | Median (IQR) | 55(32–100) | |
| Median (95%CI) | 55(49,61) | ||
aAntiretroviral therapy b Cotrimoxazole Prohylactic therapy c number of HCF visited until diagnosis of TB is made, d number of total visits made to different HCF until TB diagnosis